Ogawa M
Gan To Kagaku Ryoho. 1985 Mar;12(3 Pt 2):595-600.
Information exchange with regard to new antitumor agents has taken place through meetings dealing with various treatment areas within the US-Japan Cancer Research Program, contact between the National Cancer Institute (NCI) in the USA and the Cancer Chemotherapy Center, and meetings of the Early Clinical Trial Group of the EORTC. Cisplatin. VP16-213, 6-Thioguanine, DTIC and AMSA which were judged to be worth introducing to Japan from information obtained from the above sources were supplied by the NCI and clinical trials have been conducted. A joint study of advanced gastric cancer was conducted between the Northern California Oncology Group and a Japanese Cooperative Group involving 13 major institutions through the US-Japan Program. The study was meaningful for understanding the natural history of patients with gastric cancer in both countries.
关于新型抗肿瘤药物的信息交流，是通过美日癌症研究项目中涉及各个治疗领域的会议、美国国立癌症研究所（NCI）与癌症化疗中心之间的联系以及欧洲癌症研究与治疗组织（EORTC）早期临床试验小组的会议进行的。顺铂、依托泊苷（VP16 - 213）、6 - 硫鸟嘌呤、达卡巴嗪和安吖啶，根据从上述来源获得的信息判断，被认为值得引入日本，由美国国立癌症研究所提供，并已进行了临床试验。北加利福尼亚肿瘤学组和一个由13个主要机构组成的日本合作组通过美日项目对晚期胃癌进行了联合研究。该研究对于了解两国胃癌患者的自然病史具有重要意义。
